| Characteristic | Share of programs |
|---|---|
| Anti-virulence | 10.2% |
| Cell wall synthesis- BL and/or BLI | 2.9% |
| Cell wall synthesis - Other | 13.1% |
| Central metabolism | 4.1% |
| Direct membrane effect | 27.9% |
| DNA replication/synthesis | 6.6% |
| Protein synthesis | 7.4% |
| RNA synthesis | 2% |
| Immunomodulation | 5.7% |
| Other cellular function | 7% |
| Potentiator or enabling agent | 2.5% |
| Not disclosed | 5.7% |
| Unknown | 4.5% |
| De-colonisation | 0.4% |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Loading statistic...
Download
Source
Source
Release date
June 2024
More information
Region
Worldwide
Survey time period
2023
Supplementary notes
The analysis does not include: vaccines; topical decolonizing agents; non-specific inorganic substances; biodefence agents; agents not developed for systemic use (injectable or oral formulations) or inhalation but only for topical application (e.g., creams or eye drops); new formulations of existing treatments; or extension of indication of already approved antibacterial agents.
Citation formats
